• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[The consensus of allogeneic hematopoietic transplantation for hematological diseases in China (2014)--indication, conditioning regimen and donor selection].

出版信息

Zhonghua Xue Ye Xue Za Zhi. 2014 Aug;35(8):775-80. doi: 10.3760/cma.j.issn.0253-2727.2014.08.029.

DOI:10.3760/cma.j.issn.0253-2727.2014.08.029
PMID:25152138
Abstract
摘要

相似文献

1
[The consensus of allogeneic hematopoietic transplantation for hematological diseases in China (2014)--indication, conditioning regimen and donor selection].《中国造血干细胞移植治疗血液系统疾病专家共识（2014版）——适应证、预处理方案及供者选择》
Zhonghua Xue Ye Xue Za Zhi. 2014 Aug;35(8):775-80. doi: 10.3760/cma.j.issn.0253-2727.2014.08.029.
2
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.中国血液学会关于血液系统疾病异基因造血细胞移植适应证、预处理方案及供者选择的共识。
J Hematol Oncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x.
3
[The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases].非清髓性异基因外周血造血干细胞移植治疗血液病的临床研究
Zhonghua Xue Ye Xue Za Zhi. 2003 Feb;24(2):86-9.
4
[Comparison of conditioning regimens containing or no fludarabine in nonmyeloablative allogeneic peripheral blood stem cell transplantation].[非清髓性异基因外周血干细胞移植中含或不含氟达拉滨预处理方案的比较]
Zhonghua Xue Ye Xue Za Zhi. 2003 Aug;24(8):413-5.
5
Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms.关于将脐带血纳入英国临床移植实践的标准方法的建议：预处理方案和供体选择算法。
Bone Marrow Transplant. 2009 Jul;44(1):7-12. doi: 10.1038/bmt.2008.420. Epub 2009 Jan 12.
6
Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.异基因干细胞移植前使用氟达拉滨和曲奥舒凡进行减低剂量预处理后的植入动力学和造血嵌合现象
Ann Hematol. 2007 Aug;86(8):583-9. doi: 10.1007/s00277-007-0294-6. Epub 2007 Apr 28.
7
Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia.采用异基因造血干细胞移植的低强度方案治疗血液系统肿瘤。
Haematologica. 2000 Mar;85(3):304-13.
8
[Allogeneic hematopoietic stem cell transplantation for inherited diseases].[遗传性疾病的异基因造血干细胞移植]
Rinsho Ketsueki. 2016;57(10):2199-2207. doi: 10.11406/rinketsu.57.2199.
9
[Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases].[血液系统疾病非清髓性异基因干细胞移植的多中心报告]
Zhonghua Xue Ye Xue Za Zhi. 2009 Aug;30(8):505-8.
10
[Allogeneic hematopoietic stem cell treatment after non-myeloablation (minigraft)].非清髓性（小移植）后的异基因造血干细胞治疗
Bull Mem Acad R Med Belg. 2011;166(1-2):39-45; discussion 46-8.

引用本文的文献

1
Fertility assessment in long-term young female survivors with hematological disease after allogeneic hematopoietic cell transplantation: a single-center real-life cross-sectional study.异基因造血细胞移植后长期存活的年轻女性血液系统疾病幸存者的生育力评估：一项单中心真实世界横断面研究
Ann Hematol. 2025 Mar;104(3):1897-1905. doi: 10.1007/s00277-025-06275-4. Epub 2025 Feb 27.
2
[Clinical analysis of allogeneic hematopoietic cell transplantation in 9 patients with hematological malignancies complicated by Gilbert's syndrome].9例合并吉尔伯特综合征的血液系统恶性肿瘤患者异基因造血细胞移植的临床分析
Zhonghua Xue Ye Xue Za Zhi. 2024 Sep 14;45(9):851-855. doi: 10.3760/cma.j.cn121090-20240311-00088.
3
Porcine Anti-Lymphocyte Globulin, Cyclosporine A Plus Thrombopoietin Receptor Agonists Achieved Similar Efficacy and Survival Compared to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Aplastic Anemia.
在再生障碍性贫血患者中，猪抗淋巴细胞球蛋白、环孢素A加血小板生成素受体激动剂与异基因造血干细胞移植相比，疗效和生存率相似。
Int J Gen Med. 2024 Sep 13;17:4025-4036. doi: 10.2147/IJGM.S465184. eCollection 2024.
4
Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation.人类白细胞抗原进化分歧作为急性淋巴细胞白血病患者行单倍体造血干细胞移植时供者选择的一个新的危险因素。
Front Immunol. 2024 Aug 19;15:1440911. doi: 10.3389/fimmu.2024.1440911. eCollection 2024.
5
[Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation].异基因造血干细胞移植后人类细小病毒B19感染的临床特征
Zhonghua Xue Ye Xue Za Zhi. 2024 Jun 14;45(6):591-593. doi: 10.3760/cma.j.cn121090-20231128-00284.
6
[Risk factors for acute kidney injury after hematopoietic stem cell transplantation in children: a retrospective study].[儿童造血干细胞移植后急性肾损伤的危险因素：一项回顾性研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Oct 15;24(10):1136-1142. doi: 10.7499/j.issn.1008-8830.2205007.
7
Antinuclear Antibodies With a Nucleolar Pattern Are Associated With a Significant Reduction in the Overall Survival of Patients With Leukemia: A Retrospective Cohort Study.核仁型抗核抗体与白血病患者总生存期的显著降低相关：一项回顾性队列研究
Front Oncol. 2021 Feb 26;11:631038. doi: 10.3389/fonc.2021.631038. eCollection 2021.
8
Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.伊马替尼联合 CALLG2008 方案治疗初诊费城染色体阳性急性淋巴细胞白血病成人患者的疗效及预后因素。
Front Med. 2017 Jun;11(2):229-238. doi: 10.1007/s11684-017-0506-y. Epub 2017 Mar 27.